To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

National CFIDS Foundation, Inc.


103 Aletha Road
Needham, MA 02492-3931





Email Address

[email protected]


The National CFIDS Foundation, Inc., is an all-volunteer group dedicated to finding the cause and subsequent treatment of myalgic encephalomyelitis, also known as chronic fatigue syndrome and chronic fatigue immune dysfunction syndrome. The goals are to serve as an advocate for those affected by chronic fatigue syndrome, fund research, and provide accurate and timely information about this disease and related disorders. Established in 1987, the National CFIDS Foundation is a voluntary, not-for-profit organization providing educational materials, patient networking, patient advocacy and other services throughout the United States.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.